Finance

Lists
3349:TYO
Cosmos Pharmaceutical Corp
6 198,00 JPY
-0,21%
(-13,00) 1D
2 ოქტ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 3349...
Open
6 211 JPY
High
6 252 JPY
Low
6 135 JPY
Mkt. cap
495,85 მლრ.
Avg. vol.
429,79 ათ.
Volume
415,00 ათ.
Dividend
1,32%
Quarterly dividend
21 JPY
Ex-dividend date
27 ნოე. 2026
P/E ratio
15,33
52-wk high
8 607 JPY
52-wk low
5 615 JPY
EPS
404 JPY
Shares outstanding
19,80 მლნ.
No. of employees
6 ათ.
Open
6 211 JPY
High
6 252 JPY
Low
6 135 JPY
Mkt. cap
495,85 მლრ.
Avg. vol.
429,79 ათ.
Volume
415,00 ათ.
Dividend
1,32%
Quarterly dividend
21 JPY
Ex-dividend date
27 ნოე. 2026
P/E ratio
15,33
52-wk high
8 607 JPY
52-wk low
5 615 JPY
EPS
404 JPY
Shares outstanding
19,80 მლნ.
No. of employees
6 ათ.
News stories
From web sources and news partners
About Cosmos Pharmaceutical Corp
CEO-
Employees5,98 ათ.
Foundedდეკ 1983
Headquarters-
SectorDrug
Websitecosmospc.co.jp
Next call 10 დღეში
სამ, 13 ოქტ, 00:00
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
- / 291,21 მლრ.
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
აგვ. 2025
ნოე. 2025
თებ. 2026
მაი. 2026
Revenue
272,39 მლრ.
264,78 მლრ.
273,20 მლრ.
289,20 მლრ.
Cost of goods sold
215,22 მლრ.
209,07 მლრ.
216,15 მლრ.
229,46 მლრ.
Cost of revenue
215,22 მლრ.
209,07 მლრ.
216,15 მლრ.
229,46 მლრ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
45,64 მლრდ.
46,57 მლრდ.
45,83 მლრდ.
26,43 მლრდ.
Operating expense
45,64 მლრდ.
46,57 მლრდ.
45,83 მლრდ.
49,08 მლრდ.
Total operating expenses
260,86 მლრ.
255,64 მლრ.
261,97 მლრ.
278,54 მლრ.
Operating income
11,54 მლრდ.
9,14 მლრდ.
11,23 მლრდ.
10,66 მლრდ.
Other non operating income
627,00 მლნ.
801,00 მლნ.
667,00 მლნ.
695,00 მლნ.
EBT including unusual items
12,09 მლრდ.
9,58 მლრდ.
11,96 მლრდ.
10,60 მლრდ.
EBT excluding unusual items
12,08 მლრდ.
9,85 მლრდ.
11,81 მლრდ.
11,12 მლრდ.
Income tax expense
3,92 მლრდ.
3,10 მლრდ.
3,86 მლრდ.
1,30 მლრდ.
Effective tax rate
32,40%
32,35%
32,26%
12,26%
Other operating expenses
-
-
-
-
Net income
8,17 მლრდ.
6,48 მლრდ.
8,10 მლრდ.
9,30 მლრდ.
Net profit margin
3,00%
2,45%
2,96%
3,21%
Earnings per share
-
-
-
-
Interest and investment income
27,00 მლნ.
19,00 მლნ.
16,00 მლნ.
12,00 მლნ.
Interest expense
-110,00 მლნ.
-107,00 მლნ.
-107,00 მლნ.
-257,00 მლნ.
Net interest expenses
-83,00 მლნ.
-88,00 მლნ.
-91,00 მლნ.
-245,00 მლნ.
Depreciation and amortization charges
-
-
-
22,64 მლრდ.
EBITDA
17,09 მლრდ.
15,00 მლრდ.
16,79 მლრდ.
16,81 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები